The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.50
Bid: 107.00
Ask: 110.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.804%)
Open: 108.50
High: 108.50
Low: 108.50
Prev. Close: 108.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Update

23 Oct 2006 07:01

Intercede Group PLC23 October 2006 23 October 2006 INTERCEDE GROUP plc ('Intercede' or 'the Company') Contract Update Intercede is pleased to announce that an additional order for 200,000 MyIDlicenses has been received from Gemalto, bringing the total number of licensesordered to date to 500,000 in support of a single European public sectorcustomer. The robust and highly scalable nature of Intercede's MyID cardtechnology will enable this major customer to deliver card management servicesto over 1 million employees and contractors on a 24/7 basis. This project is oneof the largest employee focused smart card deployments in the world anddemonstrates the suitability of MyID for very large scale, complex environments. A number of key MyID features have been utilized to provide a fully scalable andintegrated solution, maximizing the use of existing infrastructure whileminimizing the risks and deployment time, including: • Integration with an in-house identity management system (IDMS) - to provide a single point of user interaction for all card and identity management • Customization of ID card issuance and management workflows to match required business processes - minimizing operator training requirements • Data retrieval from an existing central user data store - to avoid re-keying of information • Connection to a centralised Entrust Public Key Infrastructure (PKI) certificate authority for certificate production • Distributed deployment to more than 1,500 remote desktop enrolment and issuance stations for integrated card printing and chip encoding Richard Parris, Chairman and Chief Executive of Intercede, commented: "Following our recent success in the US Federal Government market, this latestorder demonstrates that MyID is able to provide both Government and CorporateEnterprises worldwide with the confidence and scalability that they require todeploy millions of smart card based identities. We are delighted to havereceived an additional license order from this prestigious Europeanorganization." About IntercedeIntercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). The Group's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, USB authenticators, biometrics, digital certificates andOpen Platform applets. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology including: Athena Smartcard Solutions,Gemalto, RSA Security, SafeNet, Thales, VeriSign and a variety of systemsintegrators and other security product and service providers. Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public Relations Tel. +44 (0)20 7743 6679Archie BerensKate Catchpole This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSTrading Update
3rd Apr 20205:07 pmRNSShare Incentive Plan
31st Mar 20207:00 amRNSReceipt of $4.6m Order
28th Feb 20207:00 amRNSShare Incentive Plan
26th Feb 20209:50 amRNSShare Incentive Plan
25th Feb 20207:00 amRNSShare Incentive Plan
12th Feb 202011:22 amRNSShare Award
25th Nov 20197:00 amRNSHalf-year Report
7th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding
18th Sep 20196:30 pmRNSResult of AGM
16th Sep 20193:56 pmRNSPosting of Annual Report & Notice of AGM
17th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSSale of Property
2nd Apr 20197:00 amRNSTrading Update
28th Feb 20197:00 amRNSNew Contract Win
4th Feb 20193:19 pmRNSHolding(s) in Company
17th Dec 201810:19 amRNSBoard Change
26th Nov 20187:00 amRNSHalf-year Report
22nd Oct 20187:00 amRNSGrant of Options
4th Oct 20187:00 amRNSTrading Statement
20th Sep 20187:00 amRNSResult of AGM
4th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSDirector/PDMR Shareholding
10th Jul 20188:00 amRNSDirector/PDMR Shareholding
29th Jun 20184:59 pmRNSPDMR Shareholding
7th Jun 20187:00 amRNSFinal Results
26th Apr 20182:10 pmRNSPDMR Change
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
20th Apr 201812:15 pmRNSPDMR Change
11th Apr 201811:36 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSAppointment of Chief Executive
4th Apr 20187:00 amRNSReceipt of $4.0m Order/Trading Update
29th Mar 20187:00 amRNSDirectorate Change
9th Mar 20187:00 amRNSNew Contract Award
13th Feb 20187:00 amRNSNew Contract Award
4th Dec 20177:00 amRNSContract
30th Nov 20177:00 amRNSNew Contract Award
27th Nov 20177:00 amRNSHalf-year Report
6th Nov 20171:58 pmRNSTrading Update
26th Oct 20177:00 amRNSShare Award
5th Oct 20177:00 amRNSTrading Statement
13th Sep 20173:30 pmRNSResult of AGM
13th Sep 20177:00 amRNSDirectorate Change
25th Aug 20177:00 amRNSIssue of Convertible Loan Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.